Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: Single center experience

Bone Marrow Transplantation

Volumn 32, Issue 4, 2003, Pages 433-436

  Mazza, P ^a   Prudenzano, A ^a   Amurri, B ^a   Palazzo, G ^a   Pisapia, G ^a   Stani, L ^a   Pricolo, G ^a  

^a Azienda Ospedaliera SS Annunziata   (Italy)

Author keywords

Blood transfusion; Jehovah's Witnesses

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; CARMUSTINE; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DOXORUBICIN; EPIRUBICIN; ERYTHROPOIETIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; METHOTREXATE; MYELOABLATIVE AGENT; PACLITAXEL; PREDNISONE; RITUXIMAB; SARCOLYSIN; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER MORTALITY; CANCER REGRESSION; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPENIA; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HEART FAILURE; HUMAN; MALE; MUCOSA INFLAMMATION; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REFRACTORY ANEMIA; RELIGION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANEMIA; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; DISEASE PROGRESSION; FEMALE; HUMANS; JEHOVAH'S WITNESSES; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; LYMPHOMA; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; RECURRENCE; RELIGION AND MEDICINE; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 0041386128     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704179     Document Type: Article

References (14)

1. Cullis JO, Ducombe AS, Dudley JM et al. Acute leukemia in Jehovah's Witness. Br J Haematol 1998; 100: 664-668.
2. Broccia G. Long-term continuous complete remission of acute myeloid leukemia in a Jehovah's Witness treated without blood support. Haematologica 1994; 79: 180-181.
3. Takeuchi S, Utsonomiya A, Makino T et al. Successful treatment for acute lymphoblastic leukemia without blood transfusion in a Jehovah's Witness. Am J Hematol 1999; 60: 168-169.
4. Fujita H, Maruta A, Koharazawa H et al. Successful treatment of a Jehovah's Witness with acute promyelocytic leukemia. Int J Hematol 1997; 65: 415-416.
5. Kerridge I, Lowe M, Seldon M et al. Clinical and ethical issues in the treatment of a Jehovah's Witness with acute myeloblastic leukemia. Arch Intern Med 1998; 157: 1753-1757.
6. Ballen KK, Ford PA, Waitkus H et al. Successful autologous bone marrow transplant without the use of blood products support. Bone Marrow Transplant 2000; 26: 1140-1141.
7. Mazza P, Palazzo G, Amurri B et al. Acute leukemia in Jehovah's Witness: a challenge for hematologists. Haematologica 2001; 85: 1221-1222.
8. Russo D, Pricolo G, Micheli MG et al. Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia. Leuk Lymphoma 2001; 40: 335-343.
9. Magrath IT. Management of high-grade lymphomas. Oncology (Hunting) 1998; 12: 40-48.
10. Multani P, White CA, Grillo-Lopez A. Non-Hodgkin's lymphomas: review of conventional treatments. Curr Pharm Biotechnol 2001; 2: 279-291.
11. Isaac N, Panzarella T, Mayers C et al. Concurrent cyclophosphamide, methotrexate, 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen. Cancer 2002; 95: 496-703.
12. Annino L, Vegna ML, Camera A et al. Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood 2002; 99: 863-871.
13. Mills W, Chopra R, McMillan A et al. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma. J Clin Oncol 1995; 13: 588-595.
14. Estrin JT, Ford PA, Henry DH et al. Erythropoietin permits high dose chemotherapy with peripheral blood stem-cell transplant for a Jehovah's Witness. Am J Hematol 1997; 55:51-52.